Increased noninvasive cardiac testing (NICT) does not lower the risk for major adverse cardiac events (MACE) within 2 years of emergency visit in patients presenting with chest pain but no acute ...

Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.

Please provide your email address to receive an email when new articles are posted on . A novel genetic test may provide clues to what caused a person’s sudden cardiac death. Testing can then be ...

The treadmill exercise test with electrocardiogram (ECG), also known as an exercise stress test, is one of the most familiar tests in medicine. While exercise testing typically is focused on ...

Adopting early noninvasive cardiac testing is a cost-effective strategy for avoiding a future heart attack or death in patients with suspected acute coronary syndrome, according to a study published ...

Please provide your email address to receive an email when new articles are posted on . Many adult survivors of childhood cancer are not regularly screened for cardiovascular disease. Primary ...

AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care-navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.

This surprisingly simple walking test is becoming a go-to tool for measuring real cardiovascular fitness—no gym, no gadgets, ...

NEW YORK, Aug. 31 (UPI) --A single blood test that measures inflammation and fat can predict women's risk for cardiovascular disease 30 years later, a new Harvard study suggests. The findings, ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...